Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Brissot
E
E
Chevallier
P
P
Guillaume
T
T
Delaunay
J
J
Ayari
S
S
Dubruille
V
V
Le Gouill
S
S
Mahe
B
B
Gastinne
T
T
Blin
N
N
Saulquin
B
B
Moreau
P
P
Harousseau
J-L
JL
Mohty
M
M
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods*; D055815:Young Adult
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D009173:Mycophenolic Acid